1
Published 2014
Canadian Agency for Drugs and Technologies in Health
... of CT scans, radiation exposure is an important public health concern. The current evidence suggests...

2
Published 2014
Canadian Agency for Drugs and Technologies in Health
... of CT scans, radiation exposure is an important public health concern. The current evidence suggests...

3
Published 2017
Canadian Agency for Drugs and Technologies in Health
...Pharmacoeconomic review report for Cerdelga...

4
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Pharmacoeconomic review report for icosapent ethyl (Vascepa)...

5
Published 2018
CADTH
...CADTH common drug review pharmacoeconomic review report for Galafold...

6
Published 2018
CADTH
...CADTH common drug review pharmacoeconomic review report for Galafold...

7
Published 2020
Canadian Agency for Drugs and Technologies in Health
...CADTH common drug review...

8
Published 2020
Canadian Agency for Drugs and Technologies in Health
...CADTH common drug review...

9
Published 2021
Canadian Agency for Drugs and Technologies in Health
...Canadian journal of health technologies...

10
Published 2011
Canadian Agency for Drugs and Technologies in Health
... coverage to include Octaplas as an alternative to FFP for certain indications. While several publications...

11
Published 2011
Canadian Agency for Drugs and Technologies in Health
... coverage to include Octaplas as an alternative to FFP for certain indications. While several publications...